<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Discharge Instructions</a></li><li><a href="#id6">Medications at Time of Discharge</a></li><li><a href="#id7">Progress Notes</a></li><li><a href="#id8">Plan of Treatment</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Results</a></li><li><a href="#id11">Visit Diagnoses</a></li><li><a href="#id12">Additional Health Concerns</a></li><li><a href="#id13">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Prostate Cancer</td><td ID="rfv2comments">Follow up</td></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>[REDACTED] 10:00 AM EST - [REDACTED] 11:59 PM EST</td><td ID="encounter3type">Hospital Encounter</td><td><p>UMHC [REDACTED] Radiation Oncology</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD PhD</p><p>[REDACTED]</p><p>Suite 1500</p><p>[REDACTED]-1002</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Prostate cancer (CMS/HCC) (Primary Dx); <br/>Lower urinary tract symptoms (LUTS)</content><br/>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist8"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td/><td ID="sochist8packsperday"/><td/><td/></tr><tr ID="sochist8smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist8cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Not Answered<br/></td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">PHQ-9 Total Score</td><td ID="sdohassess2pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex11"><td>Sex Assigned at Birth</td><td ID="BirthSex11Value">Not on file</td><td/></tr><tr ID="GenderIdentity9"><td>Gender Identity</td><td ID="GenderIdentity9Value">Not on file</td><td/></tr><tr ID="SexualOrientation10"><td>Sexual Orientation</td><td ID="SexualOrientation10Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">140</span>/<span class="content_span">69</span></td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="pulse_5749110480" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>57</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="temp_5749110480" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.6 °C (97.9 °F)</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="resp_5749110480" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>16</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="SpO2_5749110480" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>99%</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5749110480" class="xRowNormal"><td class="xcellHeader">Weight</td><td>76.2 kg (168 lb)</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="height_5749110480" class="xRowAlt"><td class="xcellHeader">Height</td><td>177.8 cm (5' 10")</td><td>[REDACTED] 10:08 AM EST</td><td/></tr><tr ID="bmi_5749110480" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>24.11</td><td>[REDACTED] 10:08 AM EST</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Discharge Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED], MD PhD - [REDACTED] 10:00 AM EST</span></p><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>- He continues to do well other than a recent trip and fall that he is recovering from.<br/>- Consider Aleve for back pain after a fall. We will check kidney function before prescribing.<br/>- Patient has an upcoming appointment with pain management.<br/>- Last PSA was obtained at PCP's office; we will request records. <br/>- Ordered new PSA [REDACTED].<br/>- Continue alfuzosin 10mg daily for urinary symptoms. <br/>- Follow up [REDACTED] with new PSA.</content><br/><span class="xLabel">Electronically signed by [REDACTED], MD PhD at [REDACTED] 11:24 AM EST</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Medications at Time of Discharge</a></h3><div><table><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%" span="2"/><col width="13%"/></colgroup><thead><tr><th>Medication</th><th>Sig</th><th>Dispensed</th><th>Refills</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr ID="dcrx21" class="xRowNormal"><td><p>metoprolol (TOPROL-XL) 25 MG 24 hr tablet</p></td><td ID="sig21"/><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx22" class="xRowAlt"><td><p>alfuzosin (UROXATRAL) 10 MG 24 hr tablet</p></td><td ID="sig22">TAKE 1 TABLET BY MOUTH DAILY WITH DINNER</td><td><p>30 tablet</p></td><td>5</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx23" class="xRowNormal"><td><p>omeprazole (PriLOSEC) 20 MG capsule</p></td><td ID="sig23">Take  by mouth.</td><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx24" class="xRowAlt"><td><p>amlodipine (NORVASC) 5 MG tablet</p></td><td ID="sig24"/><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx25" class="xRowNormal"><td><p>Combigan 0.2-0.5 % ophthalmic solution</p></td><td ID="sig25"/><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx26" class="xRowAlt"><td><p>latanoprost (XALATAN) 0.005 % ophthalmic solution</p></td><td ID="sig26">1 drop.</td><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx27" class="xRowNormal"><td><p>Vitamin A 3 MG (10000 UT) capsule</p></td><td ID="sig27">Take 10,000 Units by mouth daily.</td><td/><td/><td/><td/></tr><tr ID="dcrx28" class="xRowAlt"><td><p>Vitamin D3 (Cholecalciferol) 25 MCG (1000 UT) tablet</p></td><td ID="sig28">Take 1,000 Units by mouth daily.</td><td/><td/><td/><td/></tr><tr ID="dcrx29" class="xRowNormal"><td><p>Saw Palmetto 1000 MG CAPS</p></td><td ID="sig29">Take 1 capsule by mouth.</td><td/><td/><td/><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD PhD - [REDACTED] 10:00 AM EST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><br/>      RADIATION ONCOLOGY FOLLOW UP VISIT <br/><br/>Subjective: <br/> <br/>Patient ID: [REDACTED] is a [REDACTED]. male<br/><br/>DIAGNOSIS: Adenocarcinoma of the prostate<br/>STAGE: Favorable Intermediate, cT1bN0M0, GS 3+4=7, iPSA 10<br/> <br/>REFERRING PHYSICIAN: [REDACTED], Urology Center of [REDACTED][REDACTED]<br/> <br/>CHIEF COMPLAINT: [REDACTED] was seen [REDACTED] in the department of radiation oncology for a follow up after completing radiotherapy for prostate cancer. He is seen with [REDACTED].<br/> <br/>HISTORY OF PRESENTING ILLNESS<br/>[REDACTED] is a [REDACTED]. male who has a diagnosis of Favorable Intermediate Risk Prostate Adenocarcinoma, cT1bN0M0, GS 3+4=7, iPSA 10.<br/><br/>Radiation Treatment: This patient completed treatment on [REDACTED]. He received 42 Gy in 5 factions to the GTV and 36.25 to the PTV prostate and proximal SVs. He was treated on the ViewRay MRidian system using real-time image guided radiotherapy. He also received 6 months of ADT using an LHRH agonist. The last Lupron injection was in 8/2022.<br/><br/>Current Status: <br/>He continues to do well. He had a fall last week at a restaurant when he tripped over a rug and he is currently experiencing low back pain. He has an appointment with pain management. He has mild stable weak stream, straining, frequency, and urgency. He has occasional episodes of urge incontinence. His prior nocturia has resolved. He continues taking alfuzosin 10mg daily which help with his urinary symptoms. He continues taking laxatives as needed for constipation. He denies any blood in the urine or stool. <br/> <br/>ONCOLOGIC HISTORY:<br/>Patient was found to have an elevated PSA on routine labs. PSA 10.1 from [REDACTED] Previously 5.5 in [REDACTED] and 7.6 in [REDACTED]. He had two previous US guided biopsies which were benign with [REDACTED]. Most recently he had a US guided biopsy [REDACTED] with [REDACTED] that showed 2/18 cores GS 3+4=7, 50% core involvement. NM Bone Scan and CT Abdomen/Pelvis without contrast were both unremarkable for any obvious metastatic disease. MRI Prostate [REDACTED] showed a 1.0cm PIRADS 5 lesion in the left peripheral zone; No pelvic or inguinal lymphadenopathy.<br/><br/>Pathology:<br/>US guided biopsy [REDACTED] with [REDACTED] that showed 2/18 cores GS 3+4=7, 50% core involvement, at the left base.<br/> <br/>Imaging:<br/>NM Bone Scan and CT Abdomen/Pelvis without contrast were both unremarkable for any obvious metastatic disease. <br/> <br/>MRI Prostate [REDACTED] showed a 1.0cm PIRADS 5 lesion in the left peripheral zone; No pelvic or inguinal lymphadenopathy.<br/> <br/>Full findings and impressions from NM bone scan, CT A/P, and MRI reports to be uploaded in Media.<br/> <br/>PSA History:<br/>2020                5.5<br/>2021                2.6<br/>09/2021           10.1<br/>Completed RT [REDACTED] - [REDACTED] <br/>[REDACTED]           0.042  Testosterone &lt;3<br/>Need to obtain last PSA record from PCP; 0.1 per patient <br/><br/> <br/>IPSS History:<br/>[REDACTED]                  10<br/>[REDACTED]                    9<br/>[REDACTED]  8<br/> <br/>SHIM History:<br/>[REDACTED]                  1<br/>[REDACTED]                    1<br/>[REDACTED]  21<br/><br/> <br/>KPS: 90<br/>Pain: 0/10 and not on any pain medications currently.<br/><br/>Past Medical History: <br/>Diagnosis Date <br/>• BPH (benign prostatic hyperplasia)  <br/>• DXT (radiotherapy) [REDACTED] <br/> Prostate <br/>• Elevated PSA  <br/>• Glaucoma  <br/>• Prostate cancer (HCC) [REDACTED] <br/> GS3+4 <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/>• PROSTATE BIOPSY  12/2021 <br/><br/>History reviewed. No pertinent family history.<br/><br/>Social History <br/><br/>Socioeconomic History <br/>• Marital status: Married <br/>  Spouse name: Not on file <br/>• Number of children: Not on file <br/>• Years of education: Not on file <br/>• Highest education level: Not on file <br/>Occupational History <br/>• Not on file <br/>Tobacco Use <br/>• Smoking status: Former <br/>• Smokeless tobacco: Never <br/>Substance and Sexual Activity <br/>• Alcohol use: Not Currently <br/>• Drug use: Not Currently <br/>• Sexual activity: Not Currently <br/>Other Topics Concern <br/>• Not on file <br/>Social History Narrative <br/>• Not on file <br/><br/>Social Determinants of Health <br/><br/>Financial Resource Strain: Not on file <br/>Food Insecurity: Not on file <br/>Transportation Needs: Not on file <br/>Physical Activity: Not on file <br/>Stress: Not on file <br/>Social Connections: Not on file <br/>Intimate Partner Violence: Not on file <br/>Housing Stability: Not on file <br/><br/>Allergies <br/>Allergen Reactions <br/>• Iodine Anaphylaxis <br/><br/>Review of Systems <br/>Constitutional: Negative for activity change, diaphoresis and fatigue. <br/>HENT: Negative for congestion, rhinorrhea and sore throat.  <br/>Respiratory: Negative for cough and shortness of breath.  <br/>Cardiovascular: Negative for chest pain. <br/>Gastrointestinal: Negative for abdominal distention, abdominal pain, anal bleeding, blood in stool, constipation (controlled), diarrhea, nausea, rectal pain and vomiting. <br/>     1 BM daily with use of laxatives <br/>Genitourinary: Positive for difficulty urinating (weak stream and straining, about half the time), frequency (mild stable, less than 1 in 5 times) and urgency (mild stable, less than 1 in 5 times). Negative for decreased urine volume, dysuria, genital sores, hematuria, penile discharge, penile pain, penile swelling, scrotal swelling and testicular pain. <br/>     Nocturia 1x. Occasional episodes of urge incontinence.  <br/>Musculoskeletal: Positive for back pain (Right lower back pain after a fall about [REDACTED]). <br/>Skin: Negative for color change and rash. <br/>Neurological: Negative for weakness, light-headedness and headaches. <br/>Psychiatric/Behavioral: Negative for confusion and sleep disturbance. <br/><br/>Visit Vitals<br/>BP 140/69 (Site: Right arm, Position: Sitting, Cuff Size: Adult) <br/>Pulse 57 <br/>Temp 97.9 °F (36.6 °C) (Tympanic) <br/>Resp 16 <br/>Ht 5' 10" (1.778 m) <br/>Wt 168 lb (76.2 kg) <br/>SpO2 99% <br/>BMI 24.11 kg/m² <br/><br/>Objective: <br/>Physical Exam<br/>Constitutional:  <br/>   General: He is not in acute distress.<br/>   Appearance: Normal appearance. <br/>HENT: <br/>   Head: Normocephalic and atraumatic. <br/>Eyes: <br/>   General: No scleral icterus.<br/>   Conjunctiva/sclera: Conjunctivae normal. <br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. No respiratory distress. <br/>Abdominal: <br/>   General: Abdomen is flat. There is no distension. <br/>   Palpations: Abdomen is soft. There is no mass. <br/>   Tenderness: There is no abdominal tenderness. There is no guarding or rebound. <br/>Genitourinary:<br/>   Comments: DRE on consultation ([REDACTED]): lateral ridge of induration at the left base and an area of induration also noted at the right apex.<br/><br/>DRE on [REDACTED] performed by [REDACTED]: Flat. No palpable abnormality in the prostate or rectum. <br/>Musculoskeletal: <br/>   Cervical back: Neck supple. <br/>   Right lower leg: No edema. <br/>   Left lower leg: No edema. <br/>Lymphadenopathy: <br/>   Cervical: No cervical adenopathy. <br/>   Upper Body: <br/>   Right upper body: No supraclavicular adenopathy. <br/>   Left upper body: No supraclavicular adenopathy. <br/>   Lower Body: No right inguinal adenopathy. No left inguinal adenopathy. <br/>Skin:<br/>   General: Skin is warm and dry. <br/>Neurological: <br/>   Mental Status: He is alert and oriented to person, place, and time. <br/>Psychiatric:    <br/>   Mood and Affect: Mood normal.    <br/>   Behavior: Behavior normal. <br/><br/>Assessment: <br/>[REDACTED] is a [REDACTED]. male with Favorable Intermediate Risk Prostatic Adenocarcinoma, cT1bN0M0, GS 3+4=7, iPSA 10, currently receiving 5 fractions SBRT to the prostate.<br/><br/>He continues to do well with mild stable urinary symptoms. He continues on alfuzosin 10mg daily. Constipation is controlled with intermittent use of laxatives. His prior side effects from ADT have significantly improved. Last PSA was obtained at his PCP's office and patient believes it was at 0.1; we will request records. We will order a new PSA and CMP [REDACTED]. <br/><br/>Plan: <br/>- He continues to do well other than a recent trip and fall that he is recovering from.<br/>- Consider Aleve for back pain after a fall. We will check kidney function before prescribing.<br/>- Patient has an upcoming appointment with pain management.<br/>- Last PSA was obtained at PCP's office; we will request records. <br/>- Ordered new PSA [REDACTED].<br/>- Continue alfuzosin 10mg daily for urinary symptoms. <br/>- Follow up [REDACTED] with new PSA.<br/><br/>Physician Assistant: [REDACTED] <br/><br/> <br/>ATTENDING NOTE<br/>I INTERVIEWED, EXAMINED, AND EVALUATED THE PATIENT, AND CONCUR WITH THE NOTE BY [REDACTED], PA. I PERFORMED PERTINENT PARTS OF THE INTERVIEW, EXAM AND REVIEWED RESULTS, FURTHER MANAGEMENT/FOLLOW-UP CONSIDERATIONS AND EXPECTATIONS/PROGNOSIS. I MODIFIED THE NOTE TO REPRESENT MY FINDINGS AND RECOMMENDATIONS. I REVIEWED AND INTERPRETED  THE RECORDS AND TESTS BY OTHER PROVIDERS.<br/>[REDACTED], MD, PHD<br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD PhD at [REDACTED] 11:24 AM EST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter39" class="xRowNormal"><td>[REDACTED]  2:00 PM EDT</td><td ID="encounter39type">Appointment</td><td><p>UMHC [REDACTED] Radiation Oncology</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD PhD</p><p>[REDACTED]</p><p>Suite 1500</p><p>[REDACTED], FL 33136-1002</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure44" class="xRowNormal"><td><span class="content_span">COMPREHENSIVE METABOLIC PANEL</span></td><td>Routine</td><td>[REDACTED]  2:53 PM EDT</td><td><p>Prostate cancer (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776">results section</span>.</p></td></tr><tr ID="procedure45" class="xRowAlt"><td><span class="content_span">PSA</span></td><td>Routine</td><td>[REDACTED]  2:50 PM EDT</td><td><p>Prostate cancer (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Results</a></h3><div><ul><li>(ABNORMAL) Comprehensive metabolic panel ([REDACTED]  2:53 PM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp1Name">Glucose</td><td><span class="xflagData">111</span><span class="xflagData"> (H)</span></td><td>70 - 99 mg/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp2Name">BUN</td><td>11</td><td>8 - 27 mg/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp3Name">Creatinine</td><td>1.22</td><td>0.76 - 1.27 mg/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp4Name">eGFR</td><td>61</td><td>&gt;59 mL/min/1.73</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp5Name">BUN/Creatinine Ratio</td><td><span class="xflagData">9</span><span class="xflagData"> (L)</span></td><td>10 - 24</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp6Name">Sodium</td><td>137</td><td>134 - 144 mmol/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp7Name">Potassium</td><td>4.3</td><td>3.5 - 5.2 mmol/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp8Name">Chloride</td><td>101</td><td>96 - 106 mmol/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp9Name">CO2</td><td>24</td><td>20 - 29 mmol/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp10Name">Calcium, Serum</td><td>8.8</td><td>8.6 - 10.2 mg/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp11Name">Protein, Total, Serum</td><td>6.2</td><td>6.0 - 8.5 g/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp12Name">Albumin</td><td>4.2</td><td>3.8 - 4.8 g/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp13Name">Globulin, Total</td><td>2.0</td><td>1.5 - 4.5 g/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp14Name">Albumin/Globulin Ratio</td><td>2.1</td><td>1.2 - 2.2</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp15Name">Bilirubin, Total</td><td><span class="xflagData">2.1</span><span class="xflagData"> (H)</span></td><td>0.0 - 1.2 mg/dL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp16Name">Alkaline Phosphatase, S</td><td>104</td><td>44 - 121 IU/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp17Name">AST (SGOT)</td><td>11</td><td>0 - 40 IU/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp18Name">ALT (SGPT)</td><td><span class="content_span">7</span></td><td>0 - 44 IU/L</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Comp18Signature"/></tr><tr class="xRowAlt xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Performed At: 01<br/>Labcorp [REDACTED]<br/>[REDACTED]<br/>[REDACTED]<br/>[REDACTED] MD<br/>8008775227<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.Specimen">Blood</td><td/><td/><td>[REDACTED]  2:53 PM EDT</td><td>[REDACTED]</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD PhD</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250776.PerformingLab"><p>EXTERNAL-LABCORP (LAB)</p></td><td/><td/><td><p/></td></tr><tr><td><p>LABCORP TAMPA</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], FL 33671</p></td><td><p/></td></tr></tbody></table></li><li>PSA ([REDACTED]  2:50 PM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773.Comp1Name">PSA, Ultrasensitive</td><td><span class="content_span">0.337</span></td><td>0.000 - 4.000 ng/mL</td><td/><td/><td>LABCORP TAMPA</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Roche ECLIA methodology.<br/>According to the American Urological Association, Serum PSA should<br/>decrease and remain at undetectable levels after radical<br/>prostatectomy. The AUA defines biochemical recurrence as an initial<br/>PSA value 0.200 ng/mL or greater followed by a subsequent<br/>confirmatory PSA value 0.200 ng/mL or greater.<br/>Values obtained with different assay methods or kits cannot be used<br/>interchangeably. Results cannot be interpreted as absolute evidence<br/>of the presence or absence of malignant disease.<br/>Performed At: 01<br/>Labcorp [REDACTED]<br/>[REDACTED][REDACTED]/>[REDACTED]<br/>[REDACTED] MD<br/>8008775227<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773.Specimen">Blood</td><td>VENOUS STRUCTURE / Unknown</td><td/><td>[REDACTED]  2:50 PM EDT</td><td>[REDACTED]</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] PA</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.178250773.PerformingLab"><p>EXTERNAL-LABCORP (LAB)</p></td><td/><td/><td><p/></td></tr><tr><td><p>LABCORP TAMPA</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], [REDACTED] 33671</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id11" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (CMS/HCC)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">Lower urinary tract symptoms (LUTS)</span></p><p>Other symptoms involving urinary system</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id12" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%" span="2"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED] 10:22 AM EST</td></tr><tr class="xRowAlt"><td ID="assessment2">A fall risk assessment has been completed for the patient</td><td>[REDACTED] 10:22 AM EST</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id13" href="#toc">Care Teams</a></h3><div><table ID="ct52"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Saad de [REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]-3417</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>CLINIC/CENTER - HEALTH SERVICES</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>